Join to View Full Profile
800 Washington StBoston, MA 02111
Phone+1 617-636-5000
Dr. Comenzo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
Boston University Medical CenterResidency, Internal Medicine, 1986 - 1989
Boston University School of MedicineClass of 1986
Certifications & Licensure
MA State Medical License 1988 - 2027
NY State Medical License 1998 - 2010
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
American Board of Pathology Blood Banking/Transfusion Medicine
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Boston Magazine Castle Connolly, 2009-2013
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Join now to see all
Clinical Trials
- Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma Start of enrollment: 2000 Aug 01
- Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma Start of enrollment: 2000 Aug 01
- Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Start of enrollment: 2003 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Gene Expression Sets and Renal Profiling from the Renal AL Amyloid Involvement and NEOD00 (RAIN) Trial.Cindy Varga, Felix Eichinger, Viji Nair, Abhijit S Naik, Samih H Nasr
Kidney International Reports. 2024-09-01 - 1 citationsRenal Response Criteria for Clinical Trials in Amyloid Light Chain Amyloidosis.Nelson Leung, Raymond Comenzo, Julian Gillmore, Andrea Havasi, Efstathios Kastritis
Kidney International Reports. 2024-07-01 - 1 citationsSeeking Amyloidosis Very Early: Free light Chain Differentials and IGLV Gene Use as Screening Variables for Light-chain Amyloidosis in λ Monoclonal Gammopathies.Ping Zhou, Mahesh M Mansukhani, Raymond Yeh, Jiesheng Lu, Hongai Xia
British Journal of Cancer Research. 2024-06-01
Abstracts/Posters
- In Systemic Light-Chain Amyloidosis Complete and Very Good Partial Responses Are Not Enough: Involved Free Light Chain (iFLC) Levels < 10mg/L Are Associated with Optim...Raymond L Comenzo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- B-Cell Maturation Antigen (BCMA) in Systemic Light-Chain Amyloidosis (AL): Association with Disease Activity and Its Modulation with Gamma-Secretase InhibitionRaymond L Comenzo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Primary Results from the Phase 3 Tourmaline-AL1 Trial of Ixazomib-Dexamethasone Versus PhysicianÍs Choice of Therapy in Patients (Pts) with Relapsed/Refractory Primary...Raymond L Comenzo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Untangling Amyloidosis 201961st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Seeking AL Amyloidosis Very Early: The SAVE Trial - Identifying Clonal Lambda Light Chain Genes in Patients with MGUS or Smoldering Multiple Myeloma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
What Is Causing the National Blood Shortage?March 4th, 2022- What Doctors Want You to Know About the Potential Link Between COVID-19 and Blood TypeJune 24th, 2020
Experimental Drug Shows Promise for Rare Genetic Disorder – WebMDFebruary 11th, 2019
Grant Support
- Screening for AL Amyloidosis in Smoldering Multiple MyelomaTUFTS MEDICAL CENTER2024–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
